Table 5.
Complications, n (%) | Interventions, n (%) | ||
---|---|---|---|
Layered hyphema | 172 (30) | Hyphema washout | 26 (5) |
Transient IOP elevation >30 mmHg | 34 (6) | Anterior chamber injection of tPA | 15 (3) |
Fibrin formation in anterior chamber | 24 (4) | Posterior synechialysis, pupiloplasty | 8 (1) |
Macular edema | 22 (4) | Cataract surgery | 6 (1) |
Posterior synechia, corectopia, pupillary occlusion | 9 (2) | combined with glaucoma surgery | 5 (<1) |
cataract | 6 (1) | Sub-Tenon triamcinolone injection | 4 (<1) |
Vitreous hemorrhage | 5 (<1) | Pars-plana vitrectomy | 3 (<1) |
Blood accumulation in the lens bag | 5 (<1) | Intravitreal anti-VEGF injection | 3 (<1) |
Persistent hypotony | 4 (<1) | Nd:YAG laser capsulotomy | 2 (<1) |
Keratic precipitates, iritis | 3 (<1) | Anterior chamber paracentesis | 1 (<1) |
After cataract | 2 (<1) | Anterior chamber SF6 gas injection | 1 (<1) |
Contraction of CCC edge | 1 (<1) | Anterior chamber OVD injection | 1 (<1) |
Choroidal hemorrhage | 1 (<1) | Incision of CCC edge by Nd:YAG laser | 1 (<1) |
Branch retinal vein occlusion | 1 (<1) | ||
Age-related macular degeneration | 1 (<1) | ||
Any complications | 239 (43) | Any intervention | 63 (11) |
Abbreviations: IOP, intraoperative pressure; IFIS, intraoperative floppy iris syndrome; CCC, continuous curvilinear capsulorrhexis; tPA, tissue plasminogen activator; VEGF, vascular endothelial growth factor; Nd:YAG, neodymium:yttrium–aluminum–garnet; SF6, sulfur hexafluoride; OVD, ocular viscoelastic device.